Healthcare Infrastructure Trends Shaping the Myasthenia Gravis Disease Market
According to a new report by Polaris Market Research, the global Myasthenia Gravis Disease market was valued at USD 2.60 billion in 2024 and is projected to reach USD 6.19 billion by 2034, expanding at a CAGR of 9.1% over the forecast period. Growth is underpinned by rising adoption of biologic therapies, expanding use of personalized medicine, and accelerating clinical research...
0 Commentarii 0 Distribuiri 11 Views 0 previzualizare